Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M26.3Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M1.4EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)22.7Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book2.210-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.2PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M400,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XTL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

XTL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


XTL: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about XTL:

    News about XTL:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    Fed Holds Off Rate Hike for Now: Top 5 Gainers Sep 22 2016
    After Friday's Swoon, Should You Run for the Exits? Sep 11 2016
    XTL Biopharmaceuticals Announces the European Patent Office has Issued a Patent for its Lupus Drug... Sep 07 2016
    XTL Biopharmaceuticals to Present at Rodman & Renshaw Conference on September 12, 2016 Sep 06 2016
    Top ETFs In Neglected Telecom Sector Sep 01 2016
    XTL Biopharmaceuticals Announces New Patent Filing in U.S. for Lupus Drug hCDR1 Aug 11 2016
    More cheer for the bulls as tech stocks, financials take the baton Aug 08 2016
    Dow ETF Treads Water As Key Blue Chips Post Results That Lack Salt Jul 26 2016
    Thursday links: a tightrope walk May 26 2016
    XTL Biopharmaceuticals to Present at ChinaBio Partnering Forum 2016 in Suzhou, China on May 19, 2016 May 16 2016
    New highs for the market? May 09 2016
    Where to Invest if the Fed Stays Dovish (XLU,XTL) Apr 14 2016
    Triple digit gains in Dow Apr 12 2016
    XTL Biopharmaceuticals Completes Phase 2 Trial Design for Lead Compound hCDR1 in the Treatment of... Mar 21 2016
    Lupus Thought Leader Daphna Paran, MD, Named Medical Director of XTL Biopharmaceuticals Mar 09 2016
    XTL Biopharmaceuticals Expands Global IP Portfolio With Issued Patent in Hungary for Lupus Drug... Mar 02 2016
    XTL Biopharmaceuticals Receives European Medicines Agency's SME Status Feb 22 2016
    XTL Biopharmaceuticals' Lupus Drug hCDR1 Granted Patent for Pharmaceutical Composition &... Feb 10 2016
    XTL Biopharmaceuticals Joins Corporate Advisory Council of the Lupus Foundation of America Jan 27 2016
    XTL Biopharmaceuticals Announces Encouraging Feedback from U.S. FDA on its Upcoming IND Filing for... Jan 25 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)